UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by GSG Advisors LLC

GSG Advisors LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 652 shares of the healthcare conglomerate’s stock after purchasing an additional 63 shares during the quarter. GSG Advisors LLC’s holdings in UnitedHealth Group were worth $322,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Bell Investment Advisors Inc boosted its position in shares of UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the period. Harbor Investment Advisory LLC increased its holdings in shares of UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares during the period. Verdence Capital Advisors LLC boosted its stake in UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after purchasing an additional 342 shares during the period. Austin Private Wealth LLC increased its stake in UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares during the period. Finally, Vanguard Personalized Indexing Management LLC boosted its stake in shares of UnitedHealth Group by 7.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock worth $39,802,000 after buying an additional 5,537 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Argus boosted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Barclays increased their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, August 5th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $7.48 on Friday, hitting $558.76. The company had a trading volume of 2,976,835 shares, compared to its average volume of 4,283,194. The business has a 50 day moving average of $521.83 and a 200 day moving average of $504.89. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $591.54. The company has a market cap of $514.27 billion, a PE ratio of 34.15, a PEG ratio of 1.58 and a beta of 0.59. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the firm posted $6.14 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.50%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.